These three longitudinal population databases from Europe contain hospital dispensing records from their respective countries.
We will be at ICPE in Philadelphia, Pennsylvania: August 26 - 28, 2019. Stop by our booth (#1116) to try a database profile search and enter for a chance to win a FREE one-month subscription!
This will be an excellent time to interact with those who work directly with the resource.
*35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
We have just uploaded our 24th profile from Canada, the Discharge Abstract Database (DAD). Originally developed in 1963, DAD captures administrative, clinical and demographic information on hospital discharges (including deaths, sign-outs and transfers).
We would like to invite our subscribers to visit our 299th, 300th healthcare database profiles.
299 - Optum-Humedica De-identified Electronic Health Record (EHR) dataset (USA);
301 - BIG3 (Sweden).
It has taken us many years to reach this mark and we couldn’t do it without the help from all the database managers and their staff. Thank you!
The AACR Project Genomics, Evidence, Neoplasia, Information, Exchange (GENIE) is a multiphase, multi-year, international data-sharing project launched in November 2015. It aims to catalyze precision cancer medicine. The goal of the GENIE platform is to integrate and link clinical-grade cancer genomic data with clinical outcome data for tens of thousands of cancer patients.
We are here at Booth #32 in Prague at the International Conference on Pharmacoepidemiology. Stop by for a demo and conduct your own search!
View our latest newsletter announcing B.R.I.D.G.E. TO DATA® capabilities at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
If you will be attending, stop by booth #32 for a demo and conduct your own search!
The Spanish Rare Diseases Patient Registry [Registro Nacional de Enfermedades Raras] is a registry of national scope which collects information on all persons diagnosed with any disease considered to be rare or of low prevalence. The objectives of the registry are to:
- Provide necessary information to contribute to the development of new treatments and to the prevention, diagnosis, prognosis and quality of life of rare disease patients and their families;